207 related articles for article (PubMed ID: 20570743)
81. Period correction of the QTc of moxifloxacin with multiple predose baseline ECGs is the least variable of 4 methods tested.
Zhang X; Silkey M; Schumacher M; Wang L; Raval H; Caulfield JP
J Clin Pharmacol; 2009 May; 49(5):534-9. PubMed ID: 19287043
[TBL] [Abstract][Full Text] [Related]
82. Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14/S7B Q&As.
Rossman EI; Wisialowski TA; Vargas HM; Valentin JP; Rolf MG; Roche BM; Riley S; Pugsley MK; Nichols J; Li D; Leishman DJ; Kleiman RB; Greiter-Wilke A; Gintant GA; Engwall MJ; Delaunois A; Authier S
J Pharmacol Toxicol Methods; 2023; 123():107270. PubMed ID: 37164235
[TBL] [Abstract][Full Text] [Related]
83. Evaluation of respiratory function in freely moving Beagle dogs using implanted impedance technology.
Kearney K; Metea M; Gleason T; Edwards T; Atterson P
J Pharmacol Toxicol Methods; 2010; 62(2):119-26. PubMed ID: 20601021
[TBL] [Abstract][Full Text] [Related]
84. A new telemetry-based system for assessing cardiovascular function in group-housed large animals. Taking the 3Rs to a new level with the evaluation of remote measurement via cloud data transmission.
Markert M; Trautmann T; Krause F; Cioaga M; Mouriot S; Wetzel M; Guth BD
J Pharmacol Toxicol Methods; 2018; 93():90-97. PubMed ID: 29597013
[TBL] [Abstract][Full Text] [Related]
85. Evaluation of the guinea pig monophasic action potential (MAP) assay in predicting drug-induced delay of ventricular repolarisation using 12 clinically documented drugs.
Kågström J; Sjögren EL; Ericson AC
J Pharmacol Toxicol Methods; 2007; 56(2):186-93. PubMed ID: 17582787
[TBL] [Abstract][Full Text] [Related]
86. Results from a Joined Prospective Study to Evaluate the Sensitivity of the In Vivo Dog QT Assay in Line with the ICH E14/S7B Q&A Best Practices.
Bétat AM; Delaunois A; Delpy E; Loiseau M; Maurin A; Poizat G; Possémé C; Weinelt F; Drieu la Rochelle C; Martel E; Valentin JP
Clin Pharmacol Ther; 2024 Jul; 116(1):106-116. PubMed ID: 38709223
[TBL] [Abstract][Full Text] [Related]
87. Evaluation of the PhysioTel™ Digital M11 cardiovascular telemetry implant in socially housed cynomolgus monkeys up to 16weeks after surgery.
Andersen NK; Meyer O; Bradley A; Dragsted N; Lassen AB; Sjögren I; Larsen JM; Harvey W; Bator R; Milne A
J Pharmacol Toxicol Methods; 2017 Sep; 87():82-92. PubMed ID: 28416413
[TBL] [Abstract][Full Text] [Related]
88. A novel propellant-free inhalation drug delivery system for cardiovascular drug safety evaluation in conscious dogs.
Markert M; Klumpp A; Trautmann T; Guth B
J Pharmacol Toxicol Methods; 2004; 50(2):109-19. PubMed ID: 15385085
[TBL] [Abstract][Full Text] [Related]
89. Comparing the sensitivity of cross-over and parallel study designs for QTc assessment: An analysis based on a single large study of moxifloxacin in 48 nonhuman primates.
Leishman DJ; Holdsworth DL; Best DD; Roche BM
J Pharmacol Toxicol Methods; 2023; 123():107299. PubMed ID: 37495163
[TBL] [Abstract][Full Text] [Related]
90. Effects of Anisodine Hydrobromide on the Cardiovascular and Respiratory Functions in Conscious Dogs.
Liu Y; Wang L; Wan F; Yang N
Drug Des Devel Ther; 2020; 14():4263-4276. PubMed ID: 33116414
[TBL] [Abstract][Full Text] [Related]
91. Rat cardiovascular telemetry: Marginal distribution applied to positive control drugs.
Accardi MV; Troncy E; Abtout S; Ascah A; Maghezzi S; Authier S
J Pharmacol Toxicol Methods; 2016; 81():120-7. PubMed ID: 27039258
[TBL] [Abstract][Full Text] [Related]
92. Repeated assessment of cardiovascular and respiratory functions using combined telemetry and whole-body plethysmography in the rat.
Delaunois A; Dedoncker P; Hanon E; Guyaux M
J Pharmacol Toxicol Methods; 2009; 60(2):117-29. PubMed ID: 19616108
[TBL] [Abstract][Full Text] [Related]
93. A one-step approach to the analysis of the QT interval in conscious telemetrized dogs.
Chiang AY; Holdsworth DL; Leishman DJ
J Pharmacol Toxicol Methods; 2006; 54(2):183-8. PubMed ID: 16567113
[TBL] [Abstract][Full Text] [Related]
94. Automated blood sampling in canine telemetry studies: Enabling enhanced assessments of cardiovascular liabilities and safety margins.
Koshman YE; Wilsey AS; Bird BM; Sadilek S; Weisbecker DA; Ebert PA; Polakowski JS; Gintant GA; Mittelstadt SW; Foley CM
J Pharmacol Toxicol Methods; 2021; 109():107066. PubMed ID: 33838254
[TBL] [Abstract][Full Text] [Related]
95. Evaluating Associations Between Nonclinical Cardiovascular Functional Endpoints and Repeat-dose Cardiovascular Toxicity in the Beagle Dog: A Cross-company Initiative.
Milliken P; Aylott M; Edmunds N; Engle S; Ewart L; Fleurance R; Guffroy M; Hargreaves A; Heinz-Taheny K; Kirk S; Leishman D; Leong L; McMahon N; Valentin JP; Watson D; Wallis R; Clements P
Toxicol Sci; 2020 Jul; 176(1):224-235. PubMed ID: 32298455
[TBL] [Abstract][Full Text] [Related]
96. Automated blood sampling in canine telemetry studies: Enabling enhanced assessments of cardiovascular liabilities and safety margins.
Koshman YE; Wilsey AS; Bird BM; Sadilek S; Weisbecker DA; Ebert PA; Polakowski JS; Gintant GA; Mittelstadt SW; Foley CM
J Pharmacol Toxicol Methods; 2021; 111():107109. PubMed ID: 34416395
[TBL] [Abstract][Full Text] [Related]
97. Arrhythmogenic liability screening in cardiovascular safety pharmacology: commonality between non-clinical safety pharmacology and clinical thorough QT (TQT) studies.
Authier S; Pugsley MK; Troncy E; Curtis MJ
J Pharmacol Toxicol Methods; 2010; 62(2):83-8. PubMed ID: 20601020
[TBL] [Abstract][Full Text] [Related]
98. (-)Doxazosin is a necessary component for the hypotensive effect of (±)doxazosin during long-term administration in conscious rats.
Zhao J; Kong DZ; Li Q; Zhen YQ; Wang M; Zhao Y; Wang DK; Ren LM
Acta Pharmacol Sin; 2014 Jan; 35(1):48-57. PubMed ID: 24335843
[TBL] [Abstract][Full Text] [Related]
99. Power spectral analysis of heart rate variability in cynomolgus monkeys in safety pharmacology studies: comparative study with beagle dogs.
Champeroux P; Martel E; Jude S; Laigot C; Laveissière A; Weyn-Marotte AA; Fowler JS; Maurin A; Richard S; Babuty D
J Pharmacol Toxicol Methods; 2013; 68(1):166-74. PubMed ID: 23435316
[TBL] [Abstract][Full Text] [Related]
100. Methods of collecting and evaluating non-clinical cardiac electrophysiology data in the pharmaceutical industry: results of an international survey.
Hammond TG; Carlsson L; Davis AS; Lynch WG; MacKenzie I; Redfern WS; Sullivan AT; Camm AJ
Cardiovasc Res; 2001 Mar; 49(4):741-50. PubMed ID: 11230973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
